Loren Moss’ Post

Interview: Digital Transformation Has Revolutionized The Way Clinical Trials Are Conducted, Leading To Superior Outcomes - https://lnkd.in/gXyGX5xV - Aiswariya Chidambaram helps pharmaceutical companies and emerging biotech firms strategize their vision and roadmap.

Interview: Digital Transformation Has Revolutionized The Way Clinical Trials Are Conducted, Leading To Superior Outcomes - https://lnkd.in/gXyGX5xV - Aiswariya Chidambaram helps pharmaceutical companies and emerging biotech firms strategize their vision and roadmap.

Interview: Digital Transformation Has Revolutionized The Way Clinical Trials Are Conducted, Leading To Superior Outcomes - https://lnkd.in/gXyGX5xV - Aiswariya Chidambaram helps pharmaceutical companies and emerging biotech firms strategize their vision and roadmap.

Unlocking the full potential of clinical research management requires a strategic shift towards a platform-based approach. But why is this approach so vital? 🤔 From centralized data management to integrated compliance and governance, and enhanced collaboration, discover how this shift can transform the way you conduct clinical research. Explore the power of a platform-based transformation here: https://hubs.li/Q02p8Ksq0 Sign up for our webinar: "From Legacy to Leading Edge: Embracing Next-Gen CTMS" on Thursday, March 28 2024, at 11 AM EST: https://hubs.li/Q02p8Ksr0 #CTMS #eTMF #EDC #RTSM #Safety #PV #Pharmaceutical #Biotechnology #MedicalDevices #Diagnostics #Cloudbyz #ClinicalTrials

Even post-pandemic, healthcare and clinical trials continue to be resistant to change, including the adoption of new technology, even when such technologies provide demonstrable time and cost efficiencies. In this blog, we discuss the three barriers stonewalling clinical trial innovation. Read More: https://lnkd.in/djxzRxQA #Octalsoft #Clinicaltrial #Clinicalresearch #EclinicalSoftware #PharmaceuticalIndustry #PharmaTech #Pharma #Pharmaceutical #Healthcare #HealthcareIndustry #HealthcareSector #HealthcareInnovation #Blog #Blogs

Next-Gen Clinical Development is transforming how we bring new medicines to market. With rising costs and increasing complexity, pharma leaders need efficient, patient-centric processes. From hybrid trials to AI-driven insights, we're helping streamline clinical operations for faster, more effective outcomes. How are you optimizing your clinical trials? #ClinicalDevelopment #PharmaInnovation #AIinHealthcare #HybridTrials #NextGen

Hi Network!    Even though, surprisingly, (even after the COVID-19 pandemic), the DCT approach in clinical trials is not as popular as expected, I personally consider this topic interesting to explore and thus thought that maybe some of you would be interested in reading one more study about the current state of decentralized clinical trials. The study below gives reasons why some organizations implement DCT and what about others that don’t.   The study is based on the survey results better to understand the current state of DCT adoption and implementation. The three crucial factors were examined: organization size, technology adoption, and patient involvement.   The most interesting results are as follows, first I quote:     “There is a significant relationship (p ≈ 0.0475) between the size of an organization and its implementation of DCTs. Larger organizations are more likely to have adopted DCTs..” This is closely connected with the availability of resources and needed infrastructure for efficient implementation. The survey also highlights that technology vendors and CROs have more belief in technology as a critical factor for DCT success than biopharmaceutical companies. The study also evaluates approaches for trials the organizations use and the role of DCT.   While DCT adoption is not widespread due to clear reasons, I think the right balance between technology and the specifics of a particular organization can ensure DCT adoption for fast, efficient and diverse trials. For instance, leveraging scalable cloud-based platforms can enable small and mid-sized companies to manage and conduct DCT without significant upfront investment in infrastructure. Advanced data analytics and AI can streamline patient recruitment, monitoring, and data analysis, making the trial process more efficient and cost-effective.    💬 What are your thoughts on the survey results indicating a significant relationship between organization size and DCT implementation? https://lnkd.in/dSXDrf7n #clinicaltrials #DCT

A leading global pharma company faced costly clinical trial delays due to unreliable recruitment forecasts. With 80% of trials facing delays, they turned to Mosaic for a solution that could change the game. Mosaic developed a custom machine learning model that delivered 33% more accurate recruitment forecasts compared to their outdated off-the-shelf tool, leading to improved trial planning and better decision-making. Discover how data science transformed their clinical trial recruitment system and accelerated their path to new medicines: Read the full case study.

To maximize success while maintaining the scientific rigor of pivotal trials, quantifying and mitigating uncertainties and risks is critical. Natalia Mühlemann discusses strategies that can: ✅ help integrate dose-selection, ✅ mitigate the uncertainty about effect size, and ✅ inform primary and key secondary endpoint and patient selection. Click to learn more 👉 https://bit.ly/3SRwi1P #pharma #pharmaceutical #pharmaceuticalindustry #biotech #clinicaltrials #confirmatorytrials #Phase3 #clinicaldevelopment #drug #therapeutics #raredisease #bayesian #adaptivetrial

"advances in #scientific #AI have made this the time to leverage modern analytical tools and novel sources of #data to design more precise, efficient [clinical] trials with greater success rates." In the article "How Artificial Intelligence can Power Clinical Development" - McKinsey & Company discusses how innovation in #pharmaceutical R&D is being fuelled by developments in #ArtificialIntelligence, including #generative #AI and foundational models. Read more: 👉https://lnkd.in/eC3NQt4a #clinicaltrials #pharmaceuticals #pharma #medicine #medicaltech #healthtech #research #science #ai #artificialintellgence #researchanddevelopment #medicalindustry #medicalinnovation #healthcare #healthcareinvesting #investing #trenchant #trenchanttech #venturecapital #vc #privateequity #pe #precisionmedicine